scholarly journals In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV

2006 ◽  
Vol 58 (6) ◽  
pp. 1279-1282 ◽  
Author(s):  
M. Touyama ◽  
F. Higa ◽  
C. Nakasone ◽  
T. Shinzato ◽  
M. Akamine ◽  
...  
Keyword(s):  
Streptococcus Pneumoniae ◽  
Amino Acid ◽  
Vitro Activity ◽  
Amino Acid Substitutions ◽  
In Vitro Activity ◽  
Topoisomerase Iv ◽  
Clinical Strains ◽  
Gyrase A

scholarly journals In vitro activity of human translation initiation factor eIF4B is not affected by phosphomimetic amino acid substitutions S422D and S422E

Biochimie ◽  
2012 ◽  
Vol 94 (12) ◽  
pp. 2484-2490 ◽  
Author(s):  
Lev I. Shagam ◽  
Ilya M. Terenin ◽  
Dmitri E. Andreev ◽  
Jacov E. Dunaevsky ◽  
Sergey E. Dmitriev
Keyword(s):  
Amino Acid ◽  
Translation Initiation ◽  
Translation Initiation Factor ◽  
Vitro Activity ◽  
Initiation Factor ◽  
Amino Acid Substitutions ◽  
In Vitro Activity

scholarly journals In Vitro Activity of Ravuconazole against 923 Clinical Isolates of Nondermatophyte Filamentous Fungi

2005 ◽  
Vol 49 (12) ◽  
pp. 5136-5138 ◽  
Author(s):  
Manuel Cuenca-Estrella ◽  
Alicia Gomez-Lopez ◽  
Emilia Mellado ◽  
Guillermo Garcia-Effron ◽  
Araceli Monzon ◽  
...  
Keyword(s):  
Filamentous Fungi ◽  
Vitro Activity ◽  
Clinical Isolates ◽  
In Vitro Activity ◽  
Clinical Strains ◽  
Scedosporium Prolificans

ABSTRACT The in vitro activities of ravuconazole against 575 clinical strains of Aspergillus spp. and 348 nondermatophyte non-Aspergillus spp. were analyzed. Ravuconazole was active against Aspergillus spp., other hyaline filamentous fungi, black molds, and some Mucorales. Species such as Scedosporium prolificans, Fusarium spp., and Scopulariopsis spp. were resistant to the triazole.

scholarly journals In Vitro Activity of AR-709 against Streptococcus pneumoniae

2008 ◽  
Vol 52 (3) ◽  
pp. 1182-1183 ◽  
Author(s):  
W. T. M. Jansen ◽  
A. Verel ◽  
J. Verhoef ◽  
D. Milatovic
Keyword(s):  
Streptococcus Pneumoniae ◽  
Lower Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Multidrug Resistant ◽  
Vitro Activity ◽  
In Vitro Activity ◽  
Lower Respiratory Tract Infections ◽  
Excellent Activity ◽  
Tract Infections

ABSTRACT We investigated the in vitro activity of AR-709, a novel diaminopyrimidine antibiotic currently in development for treatment of community-acquired upper and lower respiratory tract infections, against 151 Streptococcus pneumoniae strains from various European countries. AR-709 showed excellent activity against both drug-susceptible and multidrug-resistant pneumococci.

Sign in / Sign up

Export Citation Format

Share Document